Chart 1.

Description of the clinical and laboratory characteristics of 18 patients under 15 years of age diagnosed with leprosy and followed up in a reference center in the southeastern regions of Brazil (2004-2012)

Case	Main symp­toms upon hospital admission	Home contact (yes/no - who)	Bacillo­scopy (+)	Mitsuda (mm)	PGL-1*	Sensory- motor test	EMG†	Type of reaction	Treat­ment of reaction	Type of later dis­ability
1	Neural	YES - FA­THER and MOTHER	2+	10.5	NO	Loss of protective sensibility in hands and feet	NR‡	Type 1	Corticoid	Loss of protective sensibility in hands and feet
2	Neural	YES - FA­THER and MOTHER	N§	4.5	YES	Loss of protective sensibility in hands and feet	Normal	NA||	NA	NA
3	Neural	NO	4+	0.0	NO	Loss of protective sensibility in hands	Left nail demyelin­ation	Type 1	Corticoid	Ulnar claw
4	Skin	NO	N	10.0	YES	NR	NR	NA	NA	NA
5	Neural	YES - FA­THER	1+	5.0	NO	Normal	NR	Type 1	Corticoid	NA
6	Neural	YES - FA­THER	1+	3.5	YES	Loss of protective sensibility in hands and feet	Senso­ry-motor multiple mononeu­ropathy	Type 1	Corticoid	Bilateral ulnar claw and bilat­eral tibial claw
7	Skin	NO	1+	5.0	YES	Normal	NR	NA	NA	NA
8	Skin	YES - FA­THER	N	3.0	NO	NR	NR	Type 2	Corticoid	NA
9	Skin	YES - FA­THER	5+	0.0	YES	Normal	NR	Type 2	Thalid­omide + Corticoid	NA
10	Skin	NO	4+	0.0	YES	Normal	NR	Type 1	Corticoid	NA
11	Skin	YES - TWO BROTH­ERS AND GRAND­MOTHER	N	6.0	YES	Normal	NR	NA	NA	NA
12	Neural	NO	3+	6.0	YES	Normal	NR	NA	NA	NA
13	Skin	NO	N	10.0	YES	Normal	NR	Type 1	Corticoid	Lagoph­thalmos
14	Skin	YES - MOTHER	1+	5.0	NO	NR	Flow change in the right ulnar nerve	Type 1	Corticoid	NA
15	Skin	YES -FA­THER	N	0.0	NO	NR	NR	NA	NA	NA
16	Skin	YES - MOTHER	N	5.5	NO	NR	NR	NA	NA	NA
17	Skin	NO	N	0.0	NO	NR	NR	NA	NA	NA
18	Skin	NO	N	5.0	YES	NR	NR	NA	NA	NA

Legend:

^*PGL-1=phenol glycopeptide-I;

^†EMG=Eletroneuromiography;

^‡NR=Not realized; N

^§=negative;

^||NA=Not applicable/Did not present